Despite HPV vaccines, screening will remain central for decades to control cervical cancer.
Recently, HPV testing alone or with cytology was introduced as an alternative to cytology …

Simple Summary The microbiota can modulate immune responses and modify the
physiology of the human organism, thereby increasing infective risks and a neoplastic …

Background With the advent of primary human papillomavirus testing followed by cytology
for cervical cancer screening, visual interpretation of cytology slides remains the last …

Background Pap cytology is known to be more specific but less sensitive than testing for
human papillomavirus (HPV) for the detection of high-grade cervical intraepithelial …

High-risk human papillomaviruses (HPVs) cause essentially all cervical cancers, most anal
and oropharyngeal cancers, and some vaginal, vulvar, and penile cancers. Improved …

Human papillomavirus can cause preinvasive, high-grade squamous intraepithelial lesions
(HSILs) as precursors to cancer in the anogenital area, and the microbiome is suggested to …

Importance As cervical cancer screening transitions from Papanicolaou cytologic screening
to primary human papillomavirus (HPV) testing worldwide, effective triage tests are needed …

Importance As cervical cancer screening transitions to primary human papillomavirus (HPV)
testing, effective triage and management of HPV-positive women is critical to avoid …

The persisting burden of cervical cancer in underserved populations and low-resource
regions worldwide, worsened by the onset of the COVID-19 pandemic, requires proactive …

Abstract Background: Human papillomavirus (HPV)–based cervical cancer screening
requires triage markers to decide who should be referred to colposcopy. p16/Ki-67 dual …